Medical marijuana use is associated with significant reductions in dependence on opioids and other prescription drugs, as well as an increase in quality of life, a new study has found.
This one looked at patients in Canada, analyzing the rate of prescription drug use and quality of life when incorporating cannabis into their treatment regimen. It involved 1,145 patients sourced from 21 medical clinics throughout the country.
The study, published in the journal Pain Medicine and funded by the Canadian cannabis company Tilray, found that baseline opioid use among participants dropped from 28 to 11 percent over the course of six months when marijuana was integrated into their treatment.
